Unusual 11 Mid-Day Movers 05/16: (NLST) (CTRN) (OSUR) Higher; (VELT) (AMBO) (JCP) Lower
Tweet Send to a Friend
Get Alerts VELT Hot Sheet
Trade VELT Now!
Velti plc (Nasdaq: VELT) 26.4% LOWER; reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $51.8 million versus the consensus estimate of $46.37 million. Sees Q2 2012 revenue of $55-$59 million, versus the consensus of $54.7 million. Sees FY2012 revenue of $283-$296 million, versus the consensus of $289.5 million.
Netlist, Inc. (Nasdaq: NLST) 23.7% HIGHER; reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $14 million versus the consensus estimate of $16.9 million.
Ambow Education (Nasdaq: AMBO) 20.6% LOWER; delayed the filing of its 2011 annual report. Will likely take a $1.6-$3.2 million charge related to an acquisition last year.
J.C. Penney Co., Inc. (NYSE: JCP) 17.4% LOWER; reported Q1 EPS of ($0.25), $0.15 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $3.15 billion versus the consensus estimate of $3.48 billion. Comps down 18.5% Stopping quarterly dividend. Reaffirmed FY2012 non-GAAP EPS guidance, but said it does not expect to hit its previously-issued GAAP outlook.
Savient Pharma (Nasdaq: SVNT) 15.9% LOWER; the stock appears to be breaking below the 50-day simple moving average after sticking extremely close to this technical level for the last week or so. Volume is light today.
Abercrombie & Fitch Co. (NYSE: ANF) 14.9% LOWER; reported Q1 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $921.2 million versus the consensus estimate of $951.33 million. Same store-sales were down 5 percent. Reaffirmed its FY12 EPS guidance and said it sees same-sales guidance being down by a mid-single digit percentage.
Citi Trends, Inc. (Nasdaq: CTRN) 14.7% HIGHER; reported Q1 EPS of $0.69, $0.21 better than the analyst estimate of $0.48. Revenue for the quarter came in at $197.69 million versus the consensus estimate of $196.18 million.
OraSure Technologies, Inc. (Nasdaq: OSUR) 14.0% HIGHER; announced that the U.S. FDA Blood Products Advisory Committee (BPAC) provided a unanimous positive recommendation for the Company's OraQuick In-Home HIV Test. The BPAC provides advice to the FDA on issues related to the safety and effectiveness of biological products and medical devices seeking FDA approval.
Sina Corp (Nasdaq: SINA) 12.8% HIGHER; reported Q1 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $101.5 million versus the consensus estimate of $102.56 million. Sees Q2 2012 revenue of $126-$129 million, versus the consensus of $130.44 million.
Galena Biopharma (Nasdaq: GALE) 10.6% HIGHER; traders are buying the dip following a nearly 13 percent decline over the last two trading sessions. The company issued a Q1 miss on Monday afternoon.
Legg Mason, Inc. (NYSE: LM) 9.7% HIGHER; announced today a new capital plan which includes the refinancing of $1.25 billion of convertible senior notes. The Company expects to use $250 million to be drawn on its existing revolving credit facility, other borrowings and cash on hand to repurchase the $1.25 billion convertible senior notes held by a fund managed by Kohlberg Kravis Roberts. The company's Board also authorized $1 billion for additional share repurchases.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Netlist, Inc. (Nasdaq: NLST) 23.7% HIGHER; reported Q1 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $14 million versus the consensus estimate of $16.9 million.
Ambow Education (Nasdaq: AMBO) 20.6% LOWER; delayed the filing of its 2011 annual report. Will likely take a $1.6-$3.2 million charge related to an acquisition last year.
J.C. Penney Co., Inc. (NYSE: JCP) 17.4% LOWER; reported Q1 EPS of ($0.25), $0.15 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $3.15 billion versus the consensus estimate of $3.48 billion. Comps down 18.5% Stopping quarterly dividend. Reaffirmed FY2012 non-GAAP EPS guidance, but said it does not expect to hit its previously-issued GAAP outlook.
Savient Pharma (Nasdaq: SVNT) 15.9% LOWER; the stock appears to be breaking below the 50-day simple moving average after sticking extremely close to this technical level for the last week or so. Volume is light today.
Abercrombie & Fitch Co. (NYSE: ANF) 14.9% LOWER; reported Q1 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $921.2 million versus the consensus estimate of $951.33 million. Same store-sales were down 5 percent. Reaffirmed its FY12 EPS guidance and said it sees same-sales guidance being down by a mid-single digit percentage.
Citi Trends, Inc. (Nasdaq: CTRN) 14.7% HIGHER; reported Q1 EPS of $0.69, $0.21 better than the analyst estimate of $0.48. Revenue for the quarter came in at $197.69 million versus the consensus estimate of $196.18 million.
OraSure Technologies, Inc. (Nasdaq: OSUR) 14.0% HIGHER; announced that the U.S. FDA Blood Products Advisory Committee (BPAC) provided a unanimous positive recommendation for the Company's OraQuick In-Home HIV Test. The BPAC provides advice to the FDA on issues related to the safety and effectiveness of biological products and medical devices seeking FDA approval.
Sina Corp (Nasdaq: SINA) 12.8% HIGHER; reported Q1 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $101.5 million versus the consensus estimate of $102.56 million. Sees Q2 2012 revenue of $126-$129 million, versus the consensus of $130.44 million.
Galena Biopharma (Nasdaq: GALE) 10.6% HIGHER; traders are buying the dip following a nearly 13 percent decline over the last two trading sessions. The company issued a Q1 miss on Monday afternoon.
Legg Mason, Inc. (NYSE: LM) 9.7% HIGHER; announced today a new capital plan which includes the refinancing of $1.25 billion of convertible senior notes. The Company expects to use $250 million to be drawn on its existing revolving credit facility, other borrowings and cash on hand to repurchase the $1.25 billion convertible senior notes held by a fund managed by Kohlberg Kravis Roberts. The company's Board also authorized $1 billion for additional share repurchases.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Trading Radar for 05/24: Foot Locker (FL), Hibbett (HIBB), Abercrombie (ANF) Report
- Unusual 11 Mid-Day Movers 05/21: (SDBT) (FXEN) (SCOK) Higher; (IEC) (BVX) (RSOL) Lower
- Streetinsider.com's Hot Lunchtime Reads 05/22: (MNKD) (SNE) (P) (MSFT) (SPLS)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Citi, Kohlberg Kravis Roberts, Dividend, Unusual 11 Mid-Day MoversComments
Obama
KKR and Obama pollute our economy with Paper Profits.
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
KKR
Otto Mueller on May 16, 2012 03:28 PMMark as Spam | Reply to this comment
Is Henry Kravis over 5ft. tall without his Lifts?